Fatma Unal Selected Research

Chromosome Aberrations (Chromosome Abnormalities)

11/2022	Genotoxic effects of gadobutrol and gadoversetamide active substances used in magnetic resonance imaging in human peripheral lymphocytes in vitro.
1/2022	Assessment of the genotoxic effects of antihypertensive drug active ingredient indapamide in human lymphocytes.
6/2020	In vitro genotoxicity assessment of monopotassium glutamate and magnesium diglutamate.
8/2019	Determination of genotoxic effects in hemodialysis patients with chronic kidney disease and the role of diabetes mellitus and other biochemical parameters.
6/2019	In vitro genotoxic and antigenotoxic effects of cynarin.
8/2018	Assessment of cytotoxic and genotoxic effects of enniatin-A in vitro.
2/2018	Investigation of in vitro genotoxic effects of an anti-diabetic drug sitagliptin.
1/2017	Evaluation of cytogenetic and DNA damage induced by the antidepressant drug-active ingredients, trazodone and milnacipran, in vitro.
10/2012	Genotoxicity of food preservative sodium sorbate in human lymphocytes in vitro.
6/2009	Evaluation of the genotoxicity of Fusarium mycotoxin moniliformin in human peripheral blood lymphocytes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fatma Unal Research Topics

Disease

17	Chromosome Aberrations (Chromosome Abnormalities) 11/2022 - 03/2005
2	Type 2 Diabetes Mellitus (MODY) 03/2022 - 02/2018
2	Neoplasms (Cancer) 08/2020 - 08/2013
2	Diabetes Mellitus 08/2019 - 04/2016
2	Hypertension (High Blood Pressure) 08/2019 - 04/2016
2	Chronic Renal Insufficiency 08/2019 - 04/2016
2	Genomic Instability 06/2019 - 01/2014
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Carcinoma (Carcinomatosis) 08/2018
1	Mental Disorders (Mental Disorder) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014
1	Carcinogenesis 01/2014
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2014
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2014

Drug/Important Bio-Agent (IBA)

2	Hypoglycemic Agents (Hypoglycemics)IBA 03/2022 - 02/2018
2	Food Additives (Food Additive)IBA 06/2020 - 10/2012
2	Ferritins (Ferritin)IBA 08/2019 - 04/2016
2	Hemoglobins (Hemoglobin)IBA 08/2019 - 04/2016
2	Parathyroid Hormone (Parathormone)IBA 08/2019 - 04/2016
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 06/2019 - 06/2006
1	gadoversetamide (OptiMARK)FDA Link 11/2022
1	gadobutrolIBA 11/2022
1	Metformin (Glucophage)FDA LinkGeneric 03/2022
1	Indapamide FDA LinkGeneric 01/2022
1	pullulanIBA 10/2021
1	Antitussive Agents (Antitussives)FDA Link 08/2020
1	AntipyreticsIBA 08/2020
1	Amygdalin (Laetrile)IBA 08/2020
1	Glutamic Acid (Glutamate)FDA Link 06/2020
1	MagnesiumIBA 06/2020
1	Flavoring AgentsIBA 06/2020
1	cynarineIBA 06/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 06/2019
1	BromidesIBA 08/2018
1	Sitagliptin Phosphate (Januvia)FDA Link 02/2018
1	Antidepressive Agents (Antidepressants)IBA 01/2017
1	Milnacipran (Ixel)FDA Link 01/2017
1	Trazodone (Trittico)FDA LinkGeneric 01/2017
1	A-factor (Streptomyces)IBA 01/2014
1	Biological ProductsIBA 08/2013
1	Antineoplastic Agents (Antineoplastics)IBA 08/2013
1	Sorbic Acid (Potassium Sorbate)FDA LinkGeneric 10/2012
1	moniliforminIBA 06/2009
1	MycotoxinsIBA 06/2009
1	InsecticidesIBA 03/2009
1	acephateIBA 03/2009
1	Citric Acid (Citrate)FDA LinkGeneric 02/2008
1	Pharmaceutical PreparationsIBA 01/2008
1	Fluconazole (Zonal)FDA LinkGeneric 01/2008
1	SolventsIBA 06/2006
1	afuganIBA 04/2006
1	Biomarkers (Surrogate Marker)IBA 01/2006
1	AcaricidesIBA 03/2005
1	dinocapIBA 03/2005

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 08/2019 - 04/2016
1	Complementary Therapies (Alternative Medicine) 08/2020
1	Therapeutics 08/2013